Literature DB >> 11515674

Callitrichid nutrition and food sensitivity.

M A Gore1, F Brandes, F J Kaup, R Lenzner, T Mothes, A A Osman.   

Abstract

Captive callitrichids are prone to developing intestinal problems. Their captive and natural diets differ enormously, and diet has been suggested to play a major role in wasting marmoset syndrome. Proteins in wheat, soy and milk are included in callitrichid diets of most colonies and have been linked to an immune reaction in Saguinus oedipus and Callithrix jacchus. In the present study of 23 males and females of the two species, wheat protein was tested but soy and milk products were excluded. One group had wheat and the other had rice in their diet. Blood samples and biopsies from the colon were taken. Results showed changes in the colon and an immune reaction to gliadin, a wheat protein related to coeliac disease in humans. A further immune reaction was also observed. Suggestions for further study and exclusion of cereal in the diet of these small, New World primates are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11515674     DOI: 10.1111/j.1600-0684.2001.tb00007.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  10 in total

1.  Effect of gluten diet on blood innate immune gene expressions and stool consistency in Spix's Saddleback Tamarin (Leontocebus fuscicollis) raised in captivity.

Authors:  Taianara Tocantins Gomes Almeida; Maria Vivina Barros Monteiro; Rafaelle Casseb Guimarães; Alexandre Rosário Casseb; Michael Alan Huffman; Evonnildo Costa Gonçalves; Frederico Ozanan Barros Monteiro; Ednaldo Silva Filho
Journal:  Mol Biol Rep       Date:  2019-06-14       Impact factor: 2.316

2.  Digestive efficiency mediated by serum calcium predicts bone mineral density in the common marmoset (Callithrix jacchus).

Authors:  Michael R Jarcho; Michael L Power; Donna G Layne-Colon; Suzette D Tardif
Journal:  Am J Primatol       Date:  2012-11-20       Impact factor: 2.371

3.  Tranexamic Acid and Supportive Measures to Treat Wasting Marmoset Syndrome.

Authors:  Takuro Yoshimoto; Kimie Niimi; Eiki Takahashi
Journal:  Comp Med       Date:  2016-12-01       Impact factor: 0.982

4.  The Common Marmoset-Biomedical Research Animal Model Applications and Common Spontaneous Diseases.

Authors:  Hyo-Jeong Han; Sarah J Powers; Kathleen L Gabrielson
Journal:  Toxicol Pathol       Date:  2022-05-10       Impact factor: 1.930

5.  Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole.

Authors:  Joshua A Kramer; Audra M Hachey; Lynn M Wachtman; Keith G Mansfield
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

Review 6.  Clinical Management of Gastrointestinal Disease in the Common Marmoset (Callithrix jacchus).

Authors:  Casey Fitz; Anna Goodroe; Lauren Wierenga; Andres Mejia; Heather Simmons
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

7.  Serum matrix metalloproteinase 9 (MMP9) as a biochemical marker for wasting marmoset syndrome.

Authors:  Takuro Yoshimoto; Kimie Niimi; Eiki Takahashi
Journal:  J Vet Med Sci       Date:  2016-02-12       Impact factor: 1.267

8.  Food hypersensitivity-induced chronic gastrointestinal inflammation in a non-human primate model of diet-induced obesity.

Authors:  Tomris Mustafa; Qun Li; Lauren E Kelly; Anne Gibbon; Irwin Ryan; Keisha Roffey; Stephanie Simonds; Michael A Cowley; Mark W Sleeman
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

Review 9.  Possibilities and limits for using the gut microbiome to improve captive animal health.

Authors:  Jessica Diaz; Aspen T Reese
Journal:  Anim Microbiome       Date:  2021-12-29

10.  Serum albumin and body weight as biomarkers for the antemortem identification of bone and gastrointestinal disease in the common marmoset.

Authors:  Victoria K Baxter; Gillian C Shaw; Nathaniel P Sotuyo; Cathy S Carlson; Erik J Olson; M Christine Zink; Joseph L Mankowski; Robert J Adams; Eric K Hutchinson; Kelly A Metcalf Pate
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.